Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci

Infection and Immunity

Volumn 64, Issue 5, 1996, Pages 1495-1501

  Dale, James B ^a,b   Washburn, Ronald G ^c   Marques, Marisa B ^d,e,f   Wessels, Michael R ^d,e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; HYALURONIC ACID; M PROTEIN; SIGNAL PEPTIDE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BACTERIAL MEMBRANE; BACTERIAL VIRULENCE; COMPLEMENT DEPOSITION; GENE EXPRESSION; GENE SEQUENCE; IMMUNOFLUORESCENCE TEST; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN STRUCTURE; STREPTOCOCCUS GROUP A; TRANSPOSON;

EID: 0029922220     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.5.1495-1501.1996     Document Type: Article

References (36)

1. Beachey, E. H., and I. Ofek. 1976 Epithelial cell binding of group A streptococci by hpoteichoic acid on fimbriae denuded of M protein J. Exp. Med. 143:759-771
2. Beachey, E. H., G. H. Stollerman, E. Y. Chiang, T. M. Chiang, J. M. Seyer, and A. H. Kang. 1977. Purification and properties of M protein extracted from group A streptococci with pepsin: covalent structure of the amino terminal region of the type 24 M antigen. J. Exp. Med. 145:1469-1481.
3. Blaser, M. J., E. Wang, M. K. R. Tummuru, R. Washburn, S. Fujimoto, and A. Labigne. 1994. High-frequency S-Iayer protein variation in Campylobacter fetus revealed by sapA mutagenesis. Mol. Microbiol. 14:453-462.
4. Campo, R. E., D. R. Schultz, and A. L. Bisno. 1995. M proteins of group G streptococci: mechanisms of resistance to phagocytosis. J. Infect. Dis. 171:601-606.
5. Dale, J. B., E. Y. Chiang, and J. W. Lederer. 1993. Recombinant tetravalent group A streptococcal M protein vaccine. J. Immunol. 151:2188-2194.
6. Dale, J. B., J. M. Seyer, and E. H. Beachey. 1983. Type-specific immunogcnicity of a chemically synthesized peptide fragment of type 5 streptococcal M protein. J. Exp. Med. 158:1727-1732.
7. Fischetti, V. A. 1989. Streptococcal M protein: molecular design and biological behavior Clin. Microbiol. Rev. 2:285-314.
8. Fischetti, V. A., R. D. Horstman, and V. Pancholi. 1995. Location of the complement factor H binding site on streptococcal M protein. Infect. Immun. 63:149-153.
9. Fischetti, V. A, K. F. Jones, and J. R. Scott. 1985. Size variation of the M protein in group A streptococci. J. Exp. Med 161:1384-1401.
10. Foley, M. J., and W. B. Wood. 1959. Studies on the pathogenicity of group A streptococci. II. The antiphagocytic effects of the M protein and the capsular gel. J. Exp. Med. 110:617-628.
11. Haanes-Fritz, E., W. Kraus, V. Burden, J. B. Dale, and E. H. Beachey. 1988. Comparison of the leader sequences of four group A streptococcal M protein genes. Nucleic Acids Res. 16:4667-4677.
12. Hammer, C. H., G. H. Wirtz, L. Renfer, H. D. Gresham, and B. F. Tack. 1981. Large scale isolation of functionally active components of the human complement system. J. Biol. Chem. 256:3995-4006.
13. Hirsch, J. G., and A. B. Church. 1960. Studies of phagocytosis of group A streptococci by polymorphonuclear leucocytes in vitro. J Exp. Med. 111:309-322.
14. Horstman, R. D., H. J. Sievertsen, J. Knobloch, and V. A. Fischetti. 1988. Antiphagocytic activity of streptococcal M protein, selective binding of complement control protein factor II. Proc. Natl. Acad. Sci USA 85:1657-1661.
15. Horstman, R. D., H. J. Sievertsen, M. Leippe, and V. A. Fischetti. 1992. Role of fibrinogen in complement inhibition by streptococcal M protein. Infect. Immun. 60:5036-5041.
16. Jacks-Weis, J., Y. Kim, and P. P. Cleary. 1982 Restricted deposition of C3 on M+ group A streptococci: correlation with resistance to phagocytosis. J. Immunol 128:1897-1902.
17. Johnson, D. R., D. L. Stevens, and E. L. Kaplan. 1992. Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J. Infect. Dis. 166:374-382.
18. Kass, E. H., and C. V. Seastone. 1944. The rote of mucoid polysaccharide (hyaluronic acid) in the virulence of group A hemolytic streptococci. J. Exp. Med. 79:319-330
19. Lancefield, R. C. 1948. Differentiation of group A streptococci with a common R antigen into three serological types with special reference to the bactericidal test. J Exp. Med. 106:525-544.
20. Lancefield, R. C. 1962. Current knowledge of the type-specific M antigens of group A streptococci J. Immunol 89:307-313
21. LeBoeuf, R. D., R. H. Raja, G. M. Fuller, and P. H. Weigel. 1986. Human fibrinogen specifically binds hyaluronic acid J. Biol. Chem. 261:12586-12592
22. Marques, M. B., D. L. Kasper, M. K. Pangburn, and M. R. Wessels. 1992. Prevention of C3 deposition is a virulence mechanism of type III group B streptococcus capsular polysaccharide. Infect. Immun. 60:3986-3993.
23. Mouw, A. R., E. H. Beachey, and V. Burdett. 1988. Molecular evolution of streptococcal M protein cloning and nucleotide sequence of the type 24 M protein gene and relation to other genes of Streptococcus pyogenes. J. Bacteriol. 170:676-684.
24. Peterson, P. K., Y. Kim, B. J. Wilkinson, D. Schmeling, A. F. Michael, and P. G. Quie. 1978 Dichotomy between opsonization and serum complement activation by encapsulated staphylococci. Infect. Immun. 20:770-775.
25. Phillips, G. N., P. F. Flicker, C. Cohen, B. N. Manjula, and V. A. Fischetti. 1981. Streptococcal M protein: alpha-helical coiled-coil structure and arrangement on the cell surface. Proc. Natl. Acad. Sci. USA 78:4689-4693
26. Podbielskl, A., B. Melzer, and R. Lutticken, 1991. Application of the polymerase chain reaction to study the M protein (-like) gene family in beta-hemolytic streptococci. Med. Microbiol. Immunel. 180:213-227.
27. Rothbard, S. 1948. Protective effect of hyaluronidase and type-specific anti-M serum on experimental group A infections in mice. J. Exp. Med. 88:325-333.
28. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci USA 74:4767-4771.
29. Stollerman, G. H., M. Rytel, and J. Ortiz. 1963. Accessory plasma factors involved in the bactericidal test for type-specific antibody to group A streptococci. II. Human plasma cofactor(s) enhancing opsonization of encapsulated organisms. J. Exp. Med. 117:1-17.
30. Thern, A., L. Stenberg, B. Dahlback, and G. Lindahl. 1995. Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4BP), a regulatory component of the complement system. J. Immunol. 154:375-386.
31. Wessels, M. R., and M. S. Bronze. 1994. Critical role of the group A streptococcal capsule in pharyngeal colonization and infection in mice. Proc Natl. Acad. Sci. USA 91:12238-12242.
32. Wessels, M. R., J. B. Goldberg, A. E. Moses, and T. J. DiCesare. 1994. Effects on virulence of mutations in a locus essential for hyaluronic acid expression in group A streptococci. Infect Immun. 62:433-441.
33. Wessels, M. R., A. E. Moses, J. B. Goldberg, and T. J. DiCesare. 1991. Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc Natl. Acad Sci. USA 88:8317-8321.
34. Whitnack, E., and E. H. Beachey. 1982 Antiopsonic activity of fibrinogen bound to M protein on the surface of group A streptococci. J. Clin. Invest 69:1042-1048
35. Whitnack, E., and E. H. Beachey. 1985. Biochemical and biological properties of the binding of human fibrinogen to M prote in of group A streptococci. J. Bacteriol. 164:350-358.
36. Whitnack, E., A. L. Hisnu, and E. H. Beachey. 1981. Hyaluronate capsule prevents attachment of group A streptococci to mouse peritoneal macrophages. Infect. Immun 31:985-991.